Valeo Pharma Inc.

VPHIF · OTC
Analyze with AI
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Assets
Cash & Equivalents$7,502$22,501$2,043$2,836
Short-Term Investments$0$0$0$0
Receivables$6,565$5,428$1,474$1,009
Inventory$10,246$9,980$7,675$881
Other Curr. Assets$930$2,620$1,158$684
Total Curr. Assets$25,243$40,529$12,350$5,410
Property Plant & Equip (Net)$2,664$2,254$2,141$605
Goodwill$0$0$0$0
Intangibles$11,699$15,482$6,539$4,948
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,601$0$0$0
Total NC Assets$15,964$17,736$8,680$5,553
Other Assets$0$0$0$0
Total Assets$41,207$58,265$21,030$10,963
Liabilities
Payables$3,992$3,737$7,320$3,378
Short-Term Debt$4,670$794$4,899$62
Tax Payable$0$0$0$0
Deferred Revenue$0$10,500$0$0
Other Curr. Liab.$11,612$308$3,115$838
Total Curr. Liab.$20,274$15,339$15,334$4,278
LT Debt$60,499$60,647$2,770$3,200
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$771$127$873$416
Total NC Liab.$61,270$60,774$3,643$3,616
Other Liabilities$0$0$0$0
Cap. Leases$1,404$1,165$1,210$295
Total Liabilities$81,544$76,113$18,977$7,894
Equity
Pref Stock$0$0$0$0
Common Stock$31,696$26,359$24,616$15,024
Retained Earnings-$82,264-$54,456-$28,710-$14,477
AOCI-$307-$201-$319-$422
Other Equity$10,538$10,450$6,466$2,944
Total Equity-$40,337-$17,848$2,053$3,069
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$41,207$58,265$21,030$10,963
Net Debt$57,667$38,940$5,626$426